®, has covered medical news for MJH Life Sciences, 

®’s parent company, since 2021. She has written for 

 and a variety of other lifestyle publications. She attended Emerson College, where she studied journalism and publishing. Antonia enjoys traveling, cooking, yoga and all things health and wellness. Follow her on Instagram @antonialdepace or email her at 

Articles

The overgrowth of fungi could cause the immune system to stop fighting cancer, according to a study.

Gut Microbiome Can Affect Radiation Cancer Treatment

®, has been with MJH Life Sciences since 2016. She has served as an editor on both 

. Brielle is a graduate from The College of New Jersey, where she is pursuing a Master’s in Public Health (part-time). Outside of work, she enjoys spending time with family and friends, CrossFit, and wishing she had the grace and confidence of her toddler-aged daughter. Follow Brielle on Twitter @Brielle_Benyon.

Skin cancer rates have been increasing worldwide, and climate change factors – like depleting ozone layers – may be a factor.

Climate Change May Increase Skin Cancer Risk

It has been 20 years since the FDA approved a new sunscreen filter. However, a recent study evaluating curcumin could change that.

Curcumin Shows Promise as New Sunscreen Filter

Ilya Petrou, MD, is a contributing writer for 

There are an increasing number of novel immunotherapies available for patients with skin cancer, however, their numerous adverse events must be addressed. 

Immunotherapy Helps Manage Skin Disease in Patients with Cancer

Curcumin has a long history as an effective treatment for everything from chronic pain to skin infections. Nanoparticle encapsulation shows promise in meeting that challenge and opening the way for a safe, effective adjuvant to sunscreen. 

Study: Curcumin Nanoparticles as a Photoprotective Adjuvant

and joined the MJH Life Sciences team in April 2021. She graduated from Kent State University in 2018 with a bachelor's degree in journalism and a minor in sociology. Linda used to work as a creative writer for 

 and was a technical writer/regulatory specialist/purchasing agent at GM Industrial before coming on to the team. She enjoys reading, traveling, and learning new perspectives. You can reach her at 

The FDA has granted priority review to Merck’s application for pembrolizumab, a treatment for melanoma. 

FDA Sets PDUFA Date for Pembrolizumab

Researchers from UT Southwestern Medical Center have investigated a new way to use AI to determine the metastatic potential of melanoma.  

AI Used to Distinguish Metastatic Potential in Skin Cancers

Kristi Rosa joined MJH Life Sciences in 2016 and has since held several positions within the company. She helped launch the rapidly growing infectious disease news resource 

, and now serves as the main digital news writer for 

. Prior to working at the company, she served as lead copywriter and marketing coordinator at The Strand Theater. Email: krosa@onclive.com

The FDA has granted priority review to a supplemental biologics license application for pembrolizumab for the use as an adjuvant treatment in adult and pediatric patients with stage IIB or IIC melanoma following complete resection.

FDA Grants Priority Review to Adjuvant Pembrolizumab for Stage II High-Risk Melanoma

Morgan Petronelli is an associate editor for 

and joined the MJH Life Sciences team in December 2019. She graduated from Youngstown State University in 2019 with a bachelor's degree in journalism and a minor in political science. Prior to graduating, Morgan worked as the editor-in-chief of her college newspaper. She went on to work as an assignment editor at a broadcast news station in Youngstown, Ohio before joining 

She enjoys working out, listening to music, and playing with her dog Scout. You can reach her at 

Podcasts

In this episode, Alberto Pappo, MD, director, St. Jude Solid Tumor Division, discusses a registry he helped create aimed at helping physicians better understand pediatric melanoma called Molecular Analysis of Childhood MELanocytic Tumors (MACMEL).

The Cutaneous Connection: Episode 28- The Path to Understanding Pediatric Melanoma

Videos

In this video interview, David Light, CEO of Valisure, shares his thoughts on the recent sunscreen recall from Johnson & Johnson due to benzene contamination and reveals how the FDA and sun protection companies can make sure this never happens again. 